AlphaGene Inc.
This article was originally published in Start Up
Executive Summary
Genomics; Bioinformatics. Alphagene intends to use its abilities to speedily find full-length genes and determine that they are indeed novel and disease-related on behalf of Big Pharma clients. The company will use its original analytical software, itsmethod for building gene libraries, and its robotic system for determining which genes are turned off or on in normal and diseased tissue to work with drugmakers working in defined disease areas (rather than selling its set of tools to clients).